DVL2 and hepatocellular carcinoma: Mechanistic investigations showed that ASPM augments Wnt–disheveled‐2 (Dvl2)–β‐catenin signaling by directly binding to and stabilizing Dvl2 via antagonizing the autophagy system in HCC cells.